Evidence map›Paper›PMID 39982676›Full record

ArticleDrug safety2025

Effectiveness of Transformer-Based Large Language Models in Identifying Adverse Drug Reaction Relations from Unstructured Discharge Summaries in Singapore.

Yen Ling Koon, Yan Tung Lam, Hui Xing Tan, Desmond Hwee Chun Teo, Jing Wei Neo, Aaron Jun Yi Yap, Pei San Ang, Celine Ping Wei Loke, Mun Yee Tham, Siew Har Tan and 5 more

Abstract read
PubMed Publisher
In one paragraph

Article in Drug safety, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Yen Ling KoonVigilance and Compliance Branch, Health Products Regulation Group, Health Sciences Authority, 11 Biopolis Way, #11-01 Helios, Singapore, 138667, Singapore.
Yan Tung LamVigilance and Compliance Branch, Health Products Regulation Group, Health Sciences Authority, 11 Biopolis Way, #11-01 Helios, Singapore, 138667, Singapore.
Hui Xing TanVigilance and Compliance Branch, Health Products Regulation Group, Health Sciences Authority, 11 Biopolis Way, #11-01 Helios, Singapore, 138667, Singapore.
Desmond Hwee Chun TeoVigilance and Compliance Branch, Health Products Regulation Group, Health Sciences Authority, 11 Biopolis Way, #11-01 Helios, Singapore, 138667, Singapore.
Jing Wei NeoVigilance and Compliance Branch, Health Products Regulation Group, Health Sciences Authority, 11 Biopolis Way, #11-01 Helios, Singapore, 138667, Singapore.
Aaron Jun Yi YapVigilance and Compliance Branch, Health Products Regulation Group, Health Sciences Authority, 11 Biopolis Way, #11-01 Helios, Singapore, 138667, Singapore.
Pei San AngVigilance and Compliance Branch, Health Products Regulation Group, Health Sciences Authority, 11 Biopolis Way, #11-01 Helios, Singapore, 138667, Singapore.
Celine Ping Wei LokeVigilance and Compliance Branch, Health Products Regulation Group, Health Sciences Authority, 11 Biopolis Way, #11-01 Helios, Singapore, 138667, Singapore.
Mun Yee ThamVigilance and Compliance Branch, Health Products Regulation Group, Health Sciences Authority, 11 Biopolis Way, #11-01 Helios, Singapore, 138667, Singapore.
Siew Har TanVigilance and Compliance Branch, Health Products Regulation Group, Health Sciences Authority, 11 Biopolis Way, #11-01 Helios, Singapore, 138667, Singapore.
Sally Leng Bee SohVigilance and Compliance Branch, Health Products Regulation Group, Health Sciences Authority, 11 Biopolis Way, #11-01 Helios, Singapore, 138667, Singapore.
Belinda Qin Pei FooVigilance and Compliance Branch, Health Products Regulation Group, Health Sciences Authority, 11 Biopolis Way, #11-01 Helios, Singapore, 138667, Singapore.
Zheng Jye LingRegional Health System Office, National University of Singapore, National University Health System, Singapore, Singapore.
James Luen Wei YipDepartment of Cardiology, National University Heart Centre, Singapore, Singapore.
Sreemanee Raaj DorajooVigilance and Compliance Branch, Health Products Regulation Group, Health Sciences Authority, 11 Biopolis Way, #11-01 Helios, Singapore, 138667, Singapore. sreemanee_dorajoo@hsa.gov.sg.ORCID http://orcid.org/0000-0002-9613-6994

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionTransformer-based large language models (LLMs) have transformed the field of natural language processing and led to significant advancements in various text processing tasks. However, the applicability of these LLMs in identifying related drug-adverse event (AE) pairs within clinical context may be limited by the prevalent use of non-standard sentence structures and grammar.

methodNine transformer-based LLMs pre-trained on biomedical domain corpora are fine-tuned on annotated data (n = 5088) to classify drug-AE pairs in unstructured discharge summaries as causally related or unrelated. These LLMs are then validated on text segments from deidentified hospital discharge summaries from Singapore (n = 1647). To assess generalisability, the models are validated on annotated segments (n = 4418) from the Medical Information Mart for Intensive Care (MIMIC-III) database. Performance of LLMs in identifying related drug-AE pairs is then compared against a prior benchmark set by traditional machine learning models on the same data.

resultsUsing an LLM-Bidirectional long short-term memory (LLM-BiLSTM) architecture, transformer-based LLMs improve F1 score as compared to prior benchmark with BioM-ELECTRA-Large-BiLSTM showing an average F1 score improvement of 16.1% (increase from 0.64 to 0.74). Applying additional rules on the LLM-based predictions, like ignoring drug-AE pairs when the AE is a known indication of the drug, results in a further reduction in false positive rates with precision increases of up to 5.6% (0.04 increment).

conclusionTransformer-based LLMs outperform traditional machine learning methods in identifying causally related drug-AE pairs embedded within unstructured discharge summaries. Nonetheless the improvement in performance with rules indicates that LLMs still possess some degree of imperfection for this causal relation detection task.

Indexed as

Adverse Drug Reaction Reporting SystemsDrug-Related Side Effects and Adverse ReactionsNatural Language ProcessingPatient Discharge SummariesDatabases, FactualHumansLarge Language ModelsMachine LearningPatient DischargeSingapore

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.